局所ドラッグデリバリー市場：製品別、投与経路別、エンドユーザー別-2025-2030年世界予測

局所ドラッグデリバリー市場は、2023年に1,149億6,000万米ドルと評価され、2024年には1,227億3,000万米ドルに達すると予測され、CAGR 6.85%で成長し、2030年には1,828億5,000万米ドルに達すると予測されています。

局所ドラッグデリバリー市場には、皮膚や粘膜に直接適用され、局所的および全身的な効果をもたらす幅広い製品が含まれます。このドラッグデリバリーは、特定の部位をターゲットとし、全身的な副作用を軽減し、患者のコンプライアンスを向上させることができるため、非常に重要です。用途はスキンケア治療から乾癬のような慢性疾患の管理、局所的な疼痛緩和まで幅広く、最終用途分野は在宅医療、病院、商業薬局などです。主な成長要因としては、製剤技術の進歩、皮膚疾患の流行、疼痛管理や創傷治療への志向の高まりなどが挙げられます。経皮パッチやマイクロニードルなどの先進ドラッグデリバリーシステムの出現は、送達効率と患者の快適性を高める機会を生み出しています。非侵襲的な方法と個別化医療への需要が、薬剤処方と材料の技術革新を後押ししています。しかし、厳しい規制環境、高い開発コスト、潜在的な皮膚刺激性やアレルギー反応などが成長の課題となっています。さらに、規制基準や安全基準を満たすためには、より一貫性のある臨床試験結果が必要であり、これが新規参入企業の市場参入を妨げる可能性があります。市場参入企業は、生体適合性と持続可能性に優れた材料の研究、浸透技術の強化、最大限の効果を得るための局所的アプローチと全身的アプローチを組み合わせたハイブリッドシステムなどを活用することができます。ナノテクノロジーとバイオテクノロジーの学際的研究は、非常に効果的な局所療法を処方するための有望な道を提供します。課題はあるもの、化粧品や一般用医薬品を含む応用分野の拡大に強く注力することで、市場は成長する態勢を整えています。競争優位を得ようとする企業は、研究機関との提携を優先してイノベーションを加速させ、外用剤製剤の利点と用途について市場を拡大する顧客教育に投資すべきです。パーソナライズド・セラピーのソリューションを模索し、デジタルヘルス技術を活用することで、成長と消費者エンゲージメントをさらに強化することができます。

市場力学：急速に進化する局所ドラッグデリバリー市場の主要市場インサイトを公開

局所ドラッグデリバリー市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 皮膚および眼疾患の高い有病率と火傷の発生率
  • 経皮ドラッグデリバリーへの嗜好
  • 医療用自己投与と在宅ケアの必要性
• 市場抑制要因
  • 代替ドラッグデリバリーへの嗜好
• 市場機会
  • ドラッグデリバリーの進歩のための資金調達と投資
  • 治療薬の標的送達の改良開発
• 市場の課題
  • 皮膚刺激性や浸透性に関する技術的障壁
  • 薬剤の不具合と製品回収

ポーターの5つの力：局所ドラッグデリバリー市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：局所ドラッグデリバリー市場における外部からの影響の把握

外部マクロ環境要因は、局所ドラッグデリバリー市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析局所ドラッグデリバリー市場における競合情勢の把握

局所ドラッグデリバリー市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス局所ドラッグデリバリー市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、局所ドラッグデリバリー市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨局所ドラッグデリバリー市場における成功への道筋を描く

局所ドラッグデリバリー市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 皮膚疾患や眼疾患の有病率が高く、火傷の発生率も高い
    • 経皮ドラッグデリバリーの好み
    • 医療自己管理と在宅ケアの必要性
  • 抑制要因
    • 代替的なドラッグデリバリー方法の好み
  • 機会
    • ドラッグデリバリーの進歩のための資金と投資
    • 治療薬の標的送達の改善の開発
  • 課題
    • 皮膚刺激と浸透性に関する技術的障壁
    • 医薬品の失敗と製品リコール
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 局所ドラッグデリバリー市場：製品別

• 液体製剤
  • ソリューション
  • サスペンション
• 半固形製剤
  • クリーム
  • ジェル
  • ローション
  • 軟膏
  • ペースト
• 固形製剤
  • 粉末
  • 坐薬
• 経皮吸収製品
  • 経皮パッチ
  • 経皮吸収型半固形剤

第7章 局所ドラッグデリバリー市場ルートから管理へ

• 経皮ドラッグデリバリー
• 鼻腔内ドラッグデリバリー
• 眼科用ドラッグデリバリー
• 直腸内ドラッグデリバリー
• 膣内ドラッグデリバリー

第8章 局所ドラッグデリバリー市場：エンドユーザー別

• 火傷センター
• ホームケア設定
• 病院・クリニック

第9章 南北アメリカの局所ドラッグデリバリー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の局所ドラッグデリバリー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの局所ドラッグデリバリー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Absorption Systems LLC
• Bayer AG
• Cipla Limited
• Custom Converting, Inc.
• Galderma Laboratories, L.P.
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Limited
• Hisamitsu Pharmaceutical Co., Inc.
• Johnson & Johnson Services, Inc.
• MedPharm Ltd.
• Mylan N.V.
• Novartis AG
• Novartis International AG
• Pfizer Inc.
• The Lubrizol Corporation

LIST OF FIGURES

• FIGURE 1. TOPICAL DRUG DELIVERY MARKET RESEARCH PROCESS
• FIGURE 2. TOPICAL DRUG DELIVERY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. TOPICAL DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. TOPICAL DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TOPICAL DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TOPICAL DRUG DELIVERY MARKET DYNAMICS
• TABLE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 61. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 62. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 63. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 64. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 65. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 98. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 99. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 100. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 101. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 102. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 105. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 106. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 107. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 108. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 109. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 223. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 225. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 226. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 227. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 228. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 229. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 251. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 252. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 253. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 254. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 255. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 256. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 257. POLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 258. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 260. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 261. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 262. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 263. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 264. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM

The Topical Drug Delivery Market was valued at USD 114.96 billion in 2023, expected to reach USD 122.73 billion in 2024, and is projected to grow at a CAGR of 6.85%, to USD 182.85 billion by 2030.

The topical drug delivery market encompasses a broad range of products applied directly to the skin or mucous membranes, offering localized and systemic effects. This mode of drug delivery is critical due to its ability to target specific areas, reduce systemic side effects, and improve patient compliance. Applications range from skincare treatments to management of chronic conditions like psoriasis and localized pain relief, with end-use sectors including home healthcare, hospital, and commercial pharmacies. Key growth factors include technological advancements in formulation techniques, the prevalence of skin disorders, and the increasing inclination toward pain management and wound care therapies. The emergence of advanced drug delivery systems such as transdermal patches and microneedles creates opportunities to enhance delivery efficiency and patient comfort. The demand for non-invasive methods and personalized medicine drives innovation in drug formulation and materials. However, growth is challenged by the stringent regulatory environment, high development costs, and potential skin irritation or allergenic reactions. Additionally, there is a need for more consistent clinical trial outcomes to satisfy regulatory and safety standards, which can impede market entry for new players. Market players can capitalize on biocompatible and sustainable materials research, enhanced permeation techniques, and hybrid systems combining topical and systemic approaches for maximum efficacy. Cross-disciplinary research into nanotechnology and biotechnology offers promising avenues for formulating highly effective topical therapies. Despite challenges, the market is poised for growth with a strong focus on expanding application areas, including cosmeceuticals and over-the-counter medications. Companies looking to gain a competitive advantage should prioritize collaborations with research institutions to accelerate innovation and invest in market-expanding customer education about the benefits and applications of topical drug formulations. Exploring personalized therapy solutions and leveraging digital health technologies can further bolster growth and consumer engagement.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Topical Drug Delivery Market

The Topical Drug Delivery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High prevalence of skin and eye diseases and incidence of burn injuries
  • Preference for transdermal drug delivery
  • Need for medical self-administration and home care
• Market Restraints
  • Preference for alternative modes of drug delivery
• Market Opportunities
  • Funding and investments for drug delivery advancements
  • Development of improved targeted delivery of therapeutics
• Market Challenges
  • Technical barriers related to skin irritation and permeability
  • Drug failures and product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Topical Drug Delivery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Topical Drug Delivery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Topical Drug Delivery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Topical Drug Delivery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Topical Drug Delivery Market

A detailed market share analysis in the Topical Drug Delivery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Topical Drug Delivery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Topical Drug Delivery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Topical Drug Delivery Market

A strategic analysis of the Topical Drug Delivery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Absorption Systems LLC, Bayer AG, Cipla Limited, Custom Converting, Inc., Galderma Laboratories, L.P., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., MedPharm Ltd., Mylan N.V., Novartis AG, Novartis International AG, Pfizer Inc., and The Lubrizol Corporation.

Market Segmentation & Coverage

This research report categorizes the Topical Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Liquid Formulations, Semi-Solid Formulations, Solid Formulations, and Transdermal Products. The Liquid Formulations is further studied across Solutions and Suspensions. The Semi-Solid Formulations is further studied across Creams, Gels, Lotions, Ointments, and Pastes. The Solid Formulations is further studied across Powders and Suppositories. The Transdermal Products is further studied across Transdermal Patches and Transdermal Semi-Solids.
• Based on Rout to Administration, market is studied across Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, and Vaginal Drug Delivery.
• Based on End-User, market is studied across Burn Centers, Home Care Settings, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High prevalence of skin and eye diseases and incidence of burn injuries
    • 5.1.1.2. Preference for transdermal drug delivery
    • 5.1.1.3. Need for medical self-administration and home care
  • 5.1.2. Restraints
    • 5.1.2.1. Preference for alternative modes of drug delivery
  • 5.1.3. Opportunities
    • 5.1.3.1. Funding and investments for drug delivery advancements
    • 5.1.3.2. Development of improved targeted delivery of therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. Technical barriers related to skin irritation and permeability
    • 5.1.4.2. Drug failures and product recalls
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Topical Drug Delivery Market, by Product

• 6.1. Introduction
• 6.2. Liquid Formulations
  • 6.2.1. Solutions
  • 6.2.2. Suspensions
• 6.3. Semi-Solid Formulations
  • 6.3.1. Creams
  • 6.3.2. Gels
  • 6.3.3. Lotions
  • 6.3.4. Ointments
  • 6.3.5. Pastes
• 6.4. Solid Formulations
  • 6.4.1. Powders
  • 6.4.2. Suppositories
• 6.5. Transdermal Products
  • 6.5.1. Transdermal Patches
  • 6.5.2. Transdermal Semi-Solids

7. Topical Drug Delivery Market, by Rout to Administration

• 7.1. Introduction
• 7.2. Dermal Drug Delivery
• 7.3. Nasal Drug Delivery
• 7.4. Ophthalmic Drug Delivery
• 7.5. Rectal Drug Delivery
• 7.6. Vaginal Drug Delivery

8. Topical Drug Delivery Market, by End-User

• 8.1. Introduction
• 8.2. Burn Centers
• 8.3. Home Care Settings
• 8.4. Hospitals & Clinics

9. Americas Topical Drug Delivery Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Topical Drug Delivery Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Topical Drug Delivery Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Absorption Systems LLC
• 2. Bayer AG
• 3. Cipla Limited
• 4. Custom Converting, Inc.
• 5. Galderma Laboratories, L.P.
• 6. GlaxoSmithKline PLC
• 7. Glenmark Pharmaceuticals Limited
• 8. Hisamitsu Pharmaceutical Co., Inc.
• 9. Johnson & Johnson Services, Inc.
• 10. MedPharm Ltd.
• 11. Mylan N.V.
• 12. Novartis AG
• 13. Novartis International AG
• 14. Pfizer Inc.
• 15. The Lubrizol Corporation